We serve Chemical Name:2-(1-Methyl-1H-pyrazol-5-yl)pyridine CAS:938066-21-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(1-Methyl-1H-pyrazol-5-yl)pyridine
CAS.NO:938066-21-8
Synonyms:2-(1-Methyl-1H-pyrazol-5-yl)pyridine
Molecular Formula:C9H9N3
Molecular Weight:159.18800
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:295ºC at 760 mmHg
Density:1.13 g/cm3
Index of Refraction:
PSA:30.71000
Exact Mass:159.08000
LogP:1.48210
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(1-Methyl-1H-pyrazol-5-yl)pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(1-Methyl-1H-pyrazol-5-yl)pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(1-Methyl-1H-pyrazol-5-yl)pyridine Use and application,2-(1-Methyl-1H-pyrazol-5-yl)pyridine technical grade,usp/ep/jp grade.
Related News: As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. 2-(1-Methyl-1H-pyrazol-5-yl)pyridine manufacturer Two sources familiar with the situation told Reuters that the agency had cleared about 10 million doses. 2-(1-Methyl-1H-pyrazol-5-yl)pyridine supplier Darzalex has its own VRd combo trials, dubbed PERSEUS and CEPHEUS, which are testing a newly approved under-the-skin version of the J&J drug called Darzalex Faspro. The CEPHEUS trial appears to have just completed its primary analysis, according to a listing on ClinicalTrials.gov. 2-(1-Methyl-1H-pyrazol-5-yl)pyridine vendor As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. 2-(1-Methyl-1H-pyrazol-5-yl)pyridine factory This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.
